MELISSA GRIGSBY: Open Payments
NPI 1356094213 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 18 payments from 12 companies in 2025. Trend: 2023 $15 · 2024 $485 · 2025 $419
Food & beverage: $369Education: $50
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $67 |
| ABBVIE INC. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| PFIZER INC. | 2 | $46 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Amgen Inc. | 1 | $30 |
| Incyte Corporation | 1 | $25 |
| Genentech USA, Inc. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: DARZALEX, EPKINLY, KEYTRUDA, LUMAKRAS, Fabhalta, IBRANCE, JAKAFI, Phesgo.
Industry payments across TX — which companies pay providers there.
